Outcome of chronic lymphocytic leukemia patients who switched from either ibrutinib or idelalisib to alternate kinase inhibitor: A retrospective study of the French innovative leukemia organization (FILO)

MeSH terms

• Adenine / analogs & derivatives
• Drug Substitution / methods*
• France
• Humans
• Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
• Piperidines
• Protein Kinase Inhibitors / therapeutic use*
• Purines / therapeutic use
• Pyrazoles / therapeutic use
• Pyrimidines / therapeutic use
• Quinazolinones / therapeutic use
• Retrospective Studies
• Treatment Outcome